Products

SLEEP SYSTEM FOR CLINICS & RESEARCH
Compumedics Limited
Lab & Diagnostics
Compumedics offers comprehensive, FDA-cleared sleep diagnostic systems for clinics and research, including advanced PSG/EEG amplifiers, software for data acquisition and analysis, and home sleep testing devices. The platform integrates with EMR systems and is designed for high-throughput labs and research environments.
Falcon HST
Compumedics Limited
Neurology AI
Falcon™ HST by Compumedics Limited is a medical device for Home Sleep Testing (HST), designed for simple, efficient, and clinically precise diagnosis of sleep disorders like obstructive sleep apnea (OSA) through comprehensive physiological data capture and streamlined workflows.

See all 2 products →

About Compumedics

Compumedics is a global medical device company, established in 1987, that specializes in the development, manufacture, and commercialization of advanced diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company’s core mission involves defining physiological signals and transforming vast amounts of data into valuable, actionable information to facilitate more accurate diagnoses and effective therapies for serious health conditions.

For physicians, Compumedics offers a comprehensive portfolio of solutions across sleep diagnostics, neurology diagnostics, and brain research. This includes high-definition polysomnography (PSG) systems for clinical settings, portable home sleep testing devices such as Somfit, and advanced neuroimaging suites like CURRY, which integrates EEG and MEG data with other imaging modalities for in-depth brain function analysis. The company emphasizes computer-based medical products and a data-driven approach, increasingly leveraging Software-as-a-Service (SaaS) and connected platforms (e.g., Nexus 360) to enhance diagnostic capabilities and improve patient outcomes, particularly in areas like home-based epilepsy monitoring and sleep apnea testing.

Focus Areas

Sleep Diagnostics Neuro-diagnostics Brain Research Ultrasonic Blood-Flow Monitoring

Business Intelligence

Key InvestorsHerald Investment Management
PartnershipsAdventist Health System (2019), Philips (Australia) (FY25)
AcquisitionsNeuroscan (2002), DWL (2004), Compumedics Alpha Trace (2022)
TechnologyEEG-based platform, SaaS economics, cloud-native solutions, edge computing (for portable devices), AI operating system (for data analysis and interpretation)
FDA Clearances7 cleared products (estimated)

What Physicians Need to Know

Sleep Diagnostics
Compumedics offers a comprehensive range of cutting-edge technologies for diagnosing sleep disorders, including high-definition 4K PSG systems, in-lab PSG, home sleep testing (HST) devices like Falconu2122 HST, and ambulatory PSG. They provide best-in-class sleep amplifiers and analytics technologies, such as the Grael 4K PSG:EEG amplifier and Somfit/Somfit Pro, a wearable device for medical-grade home sleep monitoring that integrates with smartphones.
Neuro-diagnostics
Compumedics provides a complete suite of neurodiagnostics solutions for both clinical and research applications. This includes high-definition 4K EEG systems, home video and ambulatory EEG monitoring, long-term EEG monitoring (LTM) with up to 512 channels, and continuous EEG (cEEG) monitoring for critical care units. Their offerings extend to clinical epilepsy monitoring and EMG diagnostics, featuring best-in-class amplifiers and neuro analytics technologies like the Grael 4K EEG, Neuvo, Siesta, and Oktiu00ae portable EEG amplifier.
Brain Research
Through its Compumedics Neuroscan brand, the company specializes in advanced brain research technologies, offering world-leading solutions for EEG, ERPs, Source Localization, and Functional Neuroimaging. They are dedicated to evolving high-density EEG recordings into true functional neuroimaging methods. Key technologies include the CURRYu00ae software, a premiere multimodal neuro-imaging solution, and the Orion LifeSpanu2122 MEG system, a next-generation functional brain imaging system optimized for accurate diagnosis with high temporal and spatial resolution.
Ultrasonic Blood-Flow Monitoring
Compumedics, through its acquisition of Germany-based DWLu00ae, is a leader in Transcranial Doppler Sonography (TCD). This specialization involves the ultrasonic monitoring and analysis of blood flow velocity in the brain, enabling better detection of diseases. They are actively developing diagnostic methods in cooperation with research institutes for cutting-edge performance and ease of use, including a focus on traumatic brain injury (TBI) monitoring systems and 3D Transcranial Colour Doppler (3D TCCD)/Duplex imaging.
Physician Tip

Compumedics stands out for physicians due to its long-standing commitment to innovation and R&D since 1987, consistently delivering best-in-class amplifiers and analytics technologies across its diverse portfolio. Their high-definition solutions, such as 4K PSG and 4K EEG, provide clearer, more precise data for enhanced diagnostic accuracy. The company offers comprehensive solutions for various clinical and research settings, from in-lab studies to accessible home monitoring, improving patient outcomes and quality of life. Furthermore, their cloud-based software platforms, like Profusion Nexus360, facilitate efficient data management and real-time remote access, streamlining workflows. Compumedics' expertise in supporting pharmaceutical clinical trials with dedicated staff and a global network also makes them a valuable partner for research-focused physicians.

Compumedics' software platform is designed for seamless operation with all Compumedics amplifiers and recorders, offering unparalleled flexibility and scalability. The Profusion Nexus360 is a cloud-based solution for patient data and management, providing real-time access to data from anywhere, on any internet-accessible platform. Additionally, their EEG solutions are compatible with the Persyst ICU Monitoring package, enhancing critical care monitoring capabilities.

Products by Compumedics

2 products in the directory

SLEEP SYSTEM FOR CLINICS & RESEARCH
Compumedics Limited
Lab & Diagnostics
Compumedics offers comprehensive, FDA-cleared sleep diagnostic systems for clinics and research, including advanced PSG/EEG amplifiers, software for data acquisition and analysis, and home sleep testing devices. The platform integrates with EMR systems and is designed for high-throughput labs and research environments.
Falcon HST
Compumedics Limited
Neurology AI
Falcon™ HST by Compumedics Limited is a medical device for Home Sleep Testing (HST), designed for simple, efficient, and clinically precise diagnosis of sleep disorders like obstructive sleep apnea (OSA) through comprehensive physiological data capture and streamlined workflows.

Reviews & Opinions

No web reviews on file yet for Compumedics. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Compumedics.

Loading videos...

Videos load interactively. If none appear, search YouTube for Compumedics →

View all on YouTube

Press & Coverage

Listcorp
Compumedics betting big on sleep tech & brain scanners
Compumedics is projecting double-digit growth in FY27, driven by strong global demand for its sleep and neuro-diagnostics products, including the Somfit wearable and Orion MEG brain scanner. The company expects a significant acceleration in high-margin SaaS and recurring revenue streams with the upcoming disposable Somfit product.
2026-07
TradingView
Compumedics Delivers Record FY26 Revenue as SaaS Growth Accelerates
Compumedics reported record shipped and invoiced revenue of approximately $60.3 million for FY26, an 18% increase year-on-year, with sales orders reaching around $62.7 million. Growth in Somfit and Nexus 360 software-as-a-service (SaaS) recurring revenue increased by approximately 70%.
2026-07
Kalkine
Compumedics (ASX:CMP) Rallies After Record FY26 Revenue Update
Compumedics' shares rose after the company announced record FY26 revenue of approximately AUD 60.3 million, an 18% increase from FY25, driven by strong demand across its sleep diagnostics, neurology, MEG, and connected platform businesses. The company anticipates further double-digit revenue growth in FY27.
2026-07
Compumedics Limited (ASX:CMP)
Appointment of a Chief Commercial Officer, USA - Compumedics Limited (ASX:CMP)
Compumedics appointed Mike Stone as Chief Commercial Officer for its US operations in June 2026, aiming to accelerate growth in sleep diagnostics and neurodiagnostics. Stone brings over 20 years of medical device commercial leadership experience.
2026-06
Compumedics
Compumedics delivers record H1 FY26 sales orders; shipped revenue up 32%, positioning for stronger H2 and FY26 execution
Compumedics reported record sales orders of $34.9 million for H1 FY26, a 6% increase from H1 FY25, with shipped and invoiced revenue up 32% to $30.8 million. The company secured one MEG order and expects further MEG opportunities in H2 FY26.
2026-01
Compumedics
ABOVE GUIDANCE SALES u2013 prompts $2.15m equity raise to further accelerate growth
Compumedics raised $2.15 million in an equity raise to accelerate growth, particularly in its USA sleep and Somfit business, which saw a 150% increase in sales orders. The funds will support additional sales staff and the release of a disposable Somfit device by May 2025.
2024-12
PMC
Validation of a Neurophysiological-Based Wearable Device (Somfit) for the Assessment of Sleep in Athletes
A study published in March 2025 validated the Compumedics Somfit wearable device for assessing sleep in athletes, demonstrating a higher level of agreement with polysomnography (PSG) compared to activity-based wearables. The Somfit device records various data, including two EEG signals, pulse rate, and oxygen saturation.
2025-03
PMC - NIH
Performance Investigation of Somfit Sleep Staging Algorithm
A study investigated the accuracy of the sleep staging algorithm in Compumedics' miniaturized Somfit home sleep monitoring device. The Somfit device, attached to the patient's forehead, combines channels for a PAT-based HSAT device with neurological signals representing EEG, EOG, and EMG derivations.
2024-07

Frequently Asked Questions

Compumedics provides a comprehensive suite of products, including high-definition PSG systems like Grael 4K for sleep, and home sleep testing devices such as Somfit and Falcon HST. For neuro-diagnostics, they offer EEG amplifiers like Oktiu00ae and solutions for clinical epilepsy monitoring and Transcranial Doppler Sonography (TCD). Their Neuroscan brand specializes in brain research with advanced EEG, ERP, and MEG systems, including the Orion LifeSpanu2122 MEG.
Compumedics maintains a rigorous, globally recognized quality assurance system that adheres to various medical and manufacturing regulatory requirements. This includes certifications such as FDA (USA), CE Mark (Europe), TGA (Australia), ISO 13485 for Medical Devices, and MDSAP. Specific products like the Oktiu00ae EEG amplifier, Somfit-D, and Orion LifeSpanu2122 MEG have received FDA 510(k) clearance.
While specific pricing for Compumedics' advanced diagnostic systems is generally not publicly listed, it typically varies based on configuration and regional distribution agreements. For detailed pricing on systems like EEG amplifiers or MEG systems, which can range from tens of thousands to several million dollars, it is best to directly contact Compumedics or their authorized regional distributors to request a personalized quote.
Compumedics offers global customer support with dedicated free call numbers and email contacts for regions including the USA, Australia, and New Zealand, as well as a general global contact. They also have regional offices in Europe to provide local expertise and support. Customers can reach out via phone or online contact forms for assistance with their products.
Yes, Compumedics actively forms strategic partnerships, including long-standing distribution agreements in key markets like China for sleep and neurology diagnostics. They also have a significant partnership with Philips Australia for supplying Somfit devices to pharmacy-based sleep programs. Furthermore, Compumedics has a master agreement with Adventist Health System in the US to be a qualified vendor across their hospital campuses.
Compumedics is a publicly listed company on the Australian Securities Exchange (ASX: CMP) since 2000, demonstrating its long-term market presence and stability. The company has a global reach with subsidiaries like Neuroscan (US) and DWL (Germany), and consistently reports record sales orders and revenue. They are focused on profitable growth, increasing recurring revenue streams, and have reaffirmed positive financial guidance for upcoming fiscal years.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.